Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Familial Primary Pulmonary Hypertension

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Familial Primary Pulmonary Hypertension in 1 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Familial Primary Pulmonary Hypertension: Familial or idiopathic hypertension in the PULMONARY CIRCULATION which is not secondary to other disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cantoni, S1
Galletti, M1
Zambelli, F1
Valente, S1
Ponti, F1
Tassinari, R1
Pasquinelli, G1
Galiè, N1
Ventura, C1

Other Studies

1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Familial Primary Pulmonary Hypertension

ArticleYear
Sodium butyrate inhibits platelet-derived growth factor-induced proliferation and migration in pulmonary artery smooth muscle cells through Akt inhibition.
    The FEBS journal, 2013, Volume: 280, Issue:9

    Topics: Acetylation; Animals; Butyric Acid; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Cell

2013